Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04720417
Title Defactinib (VS-6063) Combined With VS-6766 in Patients With Metastatic Uveal Melanoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Thomas Jefferson University
Indications

uveal melanoma

Therapies

Defactinib + RO5126766

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.